EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.37B
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
489
New
Increased
Reduced
Closed

Top Buys

1 +$483M
2 +$247M
3 +$186M
4
TSM icon
TSMC
TSM
+$179M
5
MSFT icon
Microsoft
MSFT
+$143M

Top Sells

No sells this quarter

Sector Composition

1 Technology 52.03%
2 Consumer Discretionary 19.21%
3 Communication Services 9.64%
4 Healthcare 4.63%
5 Consumer Staples 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
301
Becton Dickinson
BDX
$45.1B
$463K 0.01%
+2,943
EW icon
302
Edwards Lifesciences
EW
$46.7B
$461K 0.01%
+5,752
FFIV icon
303
F5
FFIV
$17.6B
$457K 0.01%
+1,581
PLD icon
304
Prologis
PLD
$135B
$452K 0.01%
+3,418
LMT icon
305
Lockheed Martin
LMT
$136B
$448K 0.01%
+742
SRPT icon
306
Sarepta Therapeutics
SRPT
$2.26B
$445K 0.01%
+20,453
JCI icon
307
Johnson Controls International
JCI
$86.2B
$443K 0.01%
+3,384
AKAM icon
308
Akamai
AKAM
$14.1B
$442K 0.01%
+3,847
NCLH icon
309
Norwegian Cruise Line
NCLH
$9.56B
$442K 0.01%
+23,616
CB icon
310
Chubb
CB
$129B
$441K 0.01%
+1,354
IMVT icon
311
Immunovant
IMVT
$5.96B
$440K 0.01%
+17,715
AGIO icon
312
Agios Pharmaceuticals
AGIO
$2.06B
$437K 0.01%
+12,915
RARE icon
313
Ultragenyx Pharmaceutical
RARE
$2.44B
$436K 0.01%
+20,796
IRON icon
314
Disc Medicine
IRON
$2.74B
$433K 0.01%
+6,772
IMNM icon
315
Immunome
IMNM
$2.79B
$429K 0.01%
+19,638
PGR icon
316
Progressive
PGR
$118B
$427K 0.01%
+2,154
CDW icon
317
CDW
CDW
$17.1B
$426K 0.01%
+3,523
A icon
318
Agilent Technologies
A
$34.4B
$426K 0.01%
+3,734
COF icon
319
Capital One
COF
$128B
$425K 0.01%
+2,327
BCRX icon
320
BioCryst Pharmaceuticals
BCRX
$2.38B
$424K 0.01%
+44,532
VCYT icon
321
Veracyte
VCYT
$2.69B
$422K 0.01%
+13,100
RMD icon
322
ResMed
RMD
$33.2B
$419K 0.01%
+1,867
WAT icon
323
Waters Corp
WAT
$32.2B
$418K 0.01%
+1,404
PH icon
324
Parker-Hannifin
PH
$125B
$418K 0.01%
+467
DYN icon
325
Dyne Therapeutics
DYN
$3.37B
$417K 0.01%
+23,001